Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM | NASDAQ
Chart Builder DCF Calculator
$25.96
+$0.70 (+2.77%)
Sep 22, 2026, 12:45 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-79.99M -376.74M -132.53M -289.09M -370.64M -194.59M
Depreciation & Amortization
22.29M 21.93M 20.01M 14.15M 7.45M 4.74M
Stock-Based Compensation
94.24M 120.66M 98.65M 84.32M 43.57M 15.38M
Other Working Capital
-137.06M -112.03M -108.88M 249.26M 410.44M 5.29M
Other Non-Cash Items
-250.63M -2.87M -18.87M -38.48M 142.1M 9.87M
Deferred Income Tax
n/a n/a n/a n/a n/a 63.52M
Change in Working Capital
-131.02M -110.22M -116.46M 251.63M 111.25M 5.35M
Operating Cash Flow
-345.1M -347.25M -149.2M 22.53M -66.27M -95.74M
Capital Expenditures
-14.95M -8.95M -33.73M -48.95M -46.81M -16.36M
Cash Acquisitions
-78K n/a n/a 412.39M 620K 83.77M
Purchase of Investments
-1.21B -486.44M -984.34M -1.62B -777.22M -282.36M
Sales Maturities Of Investments
848.63M 680.39M 1.09B 1.2B 529.27M 198.6M
Other Investing Acitivies
254.75M n/a n/a -412.39M n/a -83.77M
Investing Cash Flow
-121.44M 185.01M 71.84M -461.34M -294.14M -100.12M
Debt Repayment
n/a -485K -2.25M -2.29M -2.12M 1.7M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 8.53M 5.62M 810K 1.1M
Financial Cash Flow
478.05M 7.74M 276.45M 111.59M 756.14M 322.32M
Net Cash Flow
11.51M -154.5M 199.09M -327.22M 395.73M 126.46M
Free Cash Flow
-360.05M -356.19M -182.93M -26.42M -113.08M -112.1M
Adj. Free Cash Flow
-454.29M -476.85M -281.57M -110.75M -156.65M -127.48M
Maintenance CapEx
n/a -8.95M n/a -113.23K n/a n/a
Growth CapEx
-14.95M n/a -33.73M -48.84M -46.81M -16.36M
Owner Earnings
-345.1M -356.19M -149.2M 22.41M -66.27M -95.74M

© 2026 bestshares.com. All rights reserved.